SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-128767
Filing Date
2018-04-24
Accepted
2018-04-24 16:06:05
Documents
6
Period of Report
2018-06-08
Effectiveness Date
2018-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d499417ddef14a.htm DEF 14A 570118
2 GRAPHIC g499417g19y79.jpg GRAPHIC 1971
3 GRAPHIC g499417g30s27.jpg GRAPHIC 27660
4 GRAPHIC g499417g44z01.jpg GRAPHIC 1269
5 GRAPHIC g499417g52c31.jpg GRAPHIC 1053
6 GRAPHIC g499417g55w67.jpg GRAPHIC 33729
  Complete submission text file 0001193125-18-128767.txt   662289
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33451 | Film No.: 18771498
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1